Dimedone → HCID 58797594、化合物
反応式
[Cl:1][C:2]1[CH:25]=[CH:24][C:5]([CH2:6][C:7]2[S:8][CH:9]=[C:10]([CH:12]3[CH2:17][CH2:16][N:15](C(OCC=C)=O)[CH2:14][CH2:13]3)[N:11]=2)=[CH:4][CH:3]=1.CC1(C)CC(=O)CC(=O)C1>C1COCC1.C1C=CC([P]([Pd]([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)[P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)=CC=1>[Cl:1][C:2]1[CH:3]=[CH:4][C:5]([CH2:6][C:7]2[S:8][CH:9]=[C:10]([CH:12]3[CH2:13][CH2:14][NH:15][CH2:16][CH2:17]3)[N:11]=2)=[CH:24][CH:25]=1参加物
実験手順
To a solution of allyl 4-[2-(4-chlorobenzyl)-1,3-thiazol-4-yl]piperidine-1-carboxylate (692 mg) in anhydrous THF (20 ml) was added dimedone (2.06 g) followed by Pd(PPh3)4 (201 mg) and the resulting mixture was stirred at room temperature for 4 hours. A further portion of dimedone (1.03 g) and Pd(PPh3)4 (100 Mg) was added and the mixture was stirred for a further 18 hours. The reaction mixture was partitioned between 1N sodium hydroxide (50 ml) and ethyl acetate (100 ml). The organics were separated, dried and evaporated to dryness. The residue was purified by column chromatography on SCX-2 stationary phase using a gradient of DCM up to 50% 7N NH3 in MeOH in dichloromethane as eluent to give 4-[2-(4-chlorobenzyl)-1,3-thiazol-4-yl]piperidine as a solid. Yield 162 mg). NMR (CDCl3): 1.8 (m, 2H), 2.2 (m, 2H), 2.4 (bs, 1H), 2.8-3.0 (m, 3H), 3.3 (m, 2H), 4.4 (s, 2H), 7.4 (m, 5H).
後処理
- stirringthe mixture was stirred for a further 18 hours
- customThe reaction mixture was partitioned between 1N sodium hydroxide (50 ml) and ethyl acetate (100 ml)
- customThe organics were separated
- customdried
- customevaporated to dryness
- customThe residue was purified by column chromatography on SCX-2 stationary phase
出典と根拠
- ORDレコード
- ord-47224396d29f460785e85542ca9fd4f5
- 出典データセット
- uspto-grants-2007_11
- 特許番号
- US07294636B2
反応ノート
読み込み中…